Literature DB >> 8539384

Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.

W H Martin1, D Delbeke, J A Patton, M P Sandler.   

Abstract

PURPOSE: To compare single photon emission computed tomography (SPECT) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET) with FDG to evaluate malignancies.
MATERIALS AND METHODS: PET and SPECT, with fluorine-18 sodium fluoride, were performed sequentially in a cylindric phantom that contained different size spheres with activity ratios of 5:1, 10:1, and 15:1. PET and SPECT were also performed in 24 patients with known or suspected malignancies.
RESULTS: Sensitivities of PET and SPECT were 2,238 cpm/microCi (82.8 cpm/MBq) and 129 cpm/microCi (4.8 cpm/MBq), respectively (reconstructed spatial resolution, 7 and 17 mm, respectively [13-cm radius of rotation]). In the phantom studies, lesions of 1.5 and 1.3 cm or more in diameter were detected with a ratio of 5:1 and 10:1, respectively, and an information density of 150 counts per square centimeter. At FDG PET, 46 hypermetabolic lesions consistent with tumor were depicted in patients; at FDG SPECT, 36 (78%) were depicted. Sensitivity of FDG SPECT was 92% for detection of malignancies 1.8 cm or more in diameter seen at FDG PET.
CONCLUSION: Findings at FDG SPECT can help differentiate benign from malignant lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8539384     DOI: 10.1148/radiology.198.1.8539384

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Multimodality imaging of an unusual case of cardiac paraganglioma.

Authors:  Deepak Thomas; Frederick D Grant; Raymond Kwong; Vania Nose; Marcelo F Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2009-03-06       Impact factor: 5.952

2.  Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Authors:  Abass Alavi; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

3.  Collimation approaches to 511-keV imaging.

Authors:  A D Waxman
Journal:  West J Med       Date:  1996-11

4.  Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.

Authors:  Kwadwo Antwi; Melpomeni Fani; Tobias Heye; Guillaume Nicolas; Christof Rottenburger; Felix Kaul; Elmar Merkle; Christoph J Zech; Daniel Boll; Deborah R Vogt; Beat Gloor; Emanuel Christ; Damian Wild
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-28       Impact factor: 9.236

5.  Comparison of uptake characteristics and prognostic value of 201Tl and 18F-FDG in esophageal cancer.

Authors:  Hyun Woo Chung; Kyung-Han Lee; Eun Jeong Lee; Su Jin Lee; Young Seok Cho; Joon Young Choi; Young Mog Shim; Kwhanmien Kim; Byung-Tae Kim
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

6.  Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions.

Authors:  Hans-J Mentzel; K Kentouche; D Sauner; C Fleischmann; S Vogt; D Gottschild; F Zintl; W A Kaiser
Journal:  Eur Radiol       Date:  2004-07-09       Impact factor: 5.315

7.  Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging.

Authors:  Eoghan E Laffan; Rachael O'Connor; Stephanie P Ryan; Veronica B Donoghue
Journal:  Pediatr Radiol       Date:  2004-04-24

8.  Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.

Authors:  Fabrice Gutman; Isabelle Gardin; Nicolas Delahaye; Hervé Rakotonirina; Anne Hitzel; Alain Manrique; Dominique Le Guludec; Pierre Véra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-23       Impact factor: 9.236

9.  Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

Authors:  I Buchmann; M Henze; S Engelbrecht; M Eisenhut; A Runz; M Schäfer; T Schilling; S Haufe; T Herrmann; U Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-23       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.